Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay.

Several existing molecular tests for multidrug-resistant tuberculosis (MDR-TB) are limited by complexity and cost, hindering their widespread application. The objective of this proof of concept study was to develop a simple Nucleic Acid Lateral Flow (NALF) immunoassay as a potential diagnostic alter...

Full description

Bibliographic Details
Main Authors: Hatairat Kamphee, Angkana Chaiprasert, Therdsak Prammananan, Natpapas Wiriyachaiporn, Airin Kanchanatavee, Tararaj Dharakul
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4565584?pdf=render
_version_ 1818235608012685312
author Hatairat Kamphee
Angkana Chaiprasert
Therdsak Prammananan
Natpapas Wiriyachaiporn
Airin Kanchanatavee
Tararaj Dharakul
author_facet Hatairat Kamphee
Angkana Chaiprasert
Therdsak Prammananan
Natpapas Wiriyachaiporn
Airin Kanchanatavee
Tararaj Dharakul
author_sort Hatairat Kamphee
collection DOAJ
description Several existing molecular tests for multidrug-resistant tuberculosis (MDR-TB) are limited by complexity and cost, hindering their widespread application. The objective of this proof of concept study was to develop a simple Nucleic Acid Lateral Flow (NALF) immunoassay as a potential diagnostic alternative, to complement conventional PCR, for the rapid molecular detection of MDR-TB. The NALF device was designed using antibodies for the indirect detection of labeled PCR amplification products. Multiplex PCR was optimized to permit the simultaneous detection of the drug resistant determining mutations in the 81-bp hot spot region of the rpoB gene (rifampicin resistance), while semi-nested PCR was optimized for the S315T mutation detection in the katG gene (isoniazid resistance). The amplification process additionally targeted a conserved region of the genes as Mycobacterium tuberculosis (Mtb) DNA control. The optimized conditions were validated with the H37Rv wild-type (WT) Mtb isolate and Mtb isolates with known mutations (MT) within the rpoB and katG genes. Results indicate the correct identification of WT (drug susceptible) and MT (drug resistant) Mtb isolates, with the least limit of detection (LOD) being 104 genomic copies per PCR reaction. NALF is a simple, rapid and low-cost device suitable for low resource settings where conventional PCR is already employed on a regular basis. Moreover, the use of antibody-based NALF to target primer-labels, without the requirement for DNA hybridization, renders the device generic, which could easily be adapted for the molecular diagnosis of other infectious and non-infectious diseases requiring nucleic acid detection.
first_indexed 2024-12-12T11:56:40Z
format Article
id doaj.art-382dc9a7b9854816bf185e283f0abc35
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T11:56:40Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-382dc9a7b9854816bf185e283f0abc352022-12-22T00:25:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01109e013779110.1371/journal.pone.0137791Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay.Hatairat KampheeAngkana ChaiprasertTherdsak PrammanananNatpapas WiriyachaipornAirin KanchanataveeTararaj DharakulSeveral existing molecular tests for multidrug-resistant tuberculosis (MDR-TB) are limited by complexity and cost, hindering their widespread application. The objective of this proof of concept study was to develop a simple Nucleic Acid Lateral Flow (NALF) immunoassay as a potential diagnostic alternative, to complement conventional PCR, for the rapid molecular detection of MDR-TB. The NALF device was designed using antibodies for the indirect detection of labeled PCR amplification products. Multiplex PCR was optimized to permit the simultaneous detection of the drug resistant determining mutations in the 81-bp hot spot region of the rpoB gene (rifampicin resistance), while semi-nested PCR was optimized for the S315T mutation detection in the katG gene (isoniazid resistance). The amplification process additionally targeted a conserved region of the genes as Mycobacterium tuberculosis (Mtb) DNA control. The optimized conditions were validated with the H37Rv wild-type (WT) Mtb isolate and Mtb isolates with known mutations (MT) within the rpoB and katG genes. Results indicate the correct identification of WT (drug susceptible) and MT (drug resistant) Mtb isolates, with the least limit of detection (LOD) being 104 genomic copies per PCR reaction. NALF is a simple, rapid and low-cost device suitable for low resource settings where conventional PCR is already employed on a regular basis. Moreover, the use of antibody-based NALF to target primer-labels, without the requirement for DNA hybridization, renders the device generic, which could easily be adapted for the molecular diagnosis of other infectious and non-infectious diseases requiring nucleic acid detection.http://europepmc.org/articles/PMC4565584?pdf=render
spellingShingle Hatairat Kamphee
Angkana Chaiprasert
Therdsak Prammananan
Natpapas Wiriyachaiporn
Airin Kanchanatavee
Tararaj Dharakul
Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay.
PLoS ONE
title Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay.
title_full Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay.
title_fullStr Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay.
title_full_unstemmed Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay.
title_short Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay.
title_sort rapid molecular detection of multidrug resistant tuberculosis by pcr nucleic acid lateral flow immunoassay
url http://europepmc.org/articles/PMC4565584?pdf=render
work_keys_str_mv AT hatairatkamphee rapidmoleculardetectionofmultidrugresistanttuberculosisbypcrnucleicacidlateralflowimmunoassay
AT angkanachaiprasert rapidmoleculardetectionofmultidrugresistanttuberculosisbypcrnucleicacidlateralflowimmunoassay
AT therdsakprammananan rapidmoleculardetectionofmultidrugresistanttuberculosisbypcrnucleicacidlateralflowimmunoassay
AT natpapaswiriyachaiporn rapidmoleculardetectionofmultidrugresistanttuberculosisbypcrnucleicacidlateralflowimmunoassay
AT airinkanchanatavee rapidmoleculardetectionofmultidrugresistanttuberculosisbypcrnucleicacidlateralflowimmunoassay
AT tararajdharakul rapidmoleculardetectionofmultidrugresistanttuberculosisbypcrnucleicacidlateralflowimmunoassay